Life Science Cares Boston

Our newest Project Onramp intern is Breetika M., a molecular biophysics and biochemistry major at Yale University! She'll be working at C4 Therapeutics, Inc. this summer as a biology intern. Thanks to Patrick Ward and the team at C4 for their commitment to hosting several Project Onramp interns. We truly appreciate the many transformational experiences you are providing. Welcome, Breetika!

We are excited to welcome Laura Kline, senior partner and chief communications officer at Flagship Pioneering, to our Boston Board of Advisors! She is looking forward to contributing to the Board of Advisors’ work to advance LSC’s mission and deepen the impact. Welcome, Laura! Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple transformative human health and sustainability products. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures.?

Just 2 ? weeks until our 9th annual Impact Breakfast—and we can't wait to see our friends and colleagues to celebrate the impact we've made together over the last year. In 2024, Life Science Cares Boston directed grants, donated goods, and volunteers to 42 incredible Boston area nonprofit organizations working in the areas of basic needs, economic opportunity, education, and health equity. Since 2016, we've partnered with 98 community-based nonprofits. Our impact keeps growing, thanks to your help! Huge thanks to our Gold Sponsor, Cooley LLP, and our LSC Champion, Courtney Tallman Thorne, for her leadership! Thank you to our current sponsors: Presenting: Takeda Gold: Cooley LLP Silver: Blue Cross Blue Shield of Massachusetts, Blueprint Medicines, Sarepta Therapeutics, and Thermo Fisher Scientific Bronze: Agios Pharmaceuticals, Alnylam Pharmaceuticals, Beam Therapeutics, Collegium Pharmaceutical, Inc., J.P. Morgan, PwC, Sanofi, Scholar Rock, stet vision LLC, Trinity Life Sciences, and WilmerHale Friend: Aera Therapeutics, Alexion Pharmaceuticals, Arbor Biotech, Biogen, The Bowdoin Group, Camp4 Therapeutics, CFGI, City Therapeutics, Corsera Health, Corval, enGene, Gallagher, Hemab, JMM Innovations, Kymera Therapeutics, Leerink Partners, Marsh McLennan, MassBio, McDermott Will & Emery, Morgan Stanley, The NemetzGroup, Newfront, Nimbus Therapeutics, Orbital Therapeutics, PathAI, Q32 Bio, Rapport Therapeutics, Schr?dinger, Synterex, Third Rock Ventures, Triumvirate Environmental, Vigil Neuro, and Xilio Therapeutics We're just about sold out! If you'd like to sponsor or purchase individual tickets, please reach out to?Emily Stanford: [email protected].

Introducing Harrison Mayer, management major at University of Massachusetts Amherst and our newest Project Onramp intern! He'll be working at Alnylam Pharmaceuticals this summer as a clinical supply chain intern. Thanks to Lada Huynh and the team at Alnylam for their significant commitment to hosting Project Onramp interns. We truly appreciate the many transformational experiences you provide each summer!

Super thankful to our hosts at Portal Innovations, LLC for sharing their office space with us each week. They are also connecting us with their tenants and other partners because they, too, are committed to growing our #NetworkOfGood. Their generous donation allows more of our funding to go directly to our Nonprofit Partners. Absolutely love this gorgeous building and Portal’s amazing support!

Our 9th annual Impact Breakfast is less than three weeks away! We can't wait to share and celebrate the impact we've made together over the last year. One way we've made an impact is with grants to our Nonprofit Partners. Since 2016, and with your support, Life Science Cares Boston has granted nearly $12M to our Nonprofit Partners working in the areas of basic needs, economic opportunity, and education (and even more in 2025 with the addition of our health equity grantmaking program)! Huge thanks to our Presenting Sponsor, Takeda, and our LSC Champions, Amy Atwood and Chris Barr, for their leadership. Thank you to our current sponsors: Presenting: Takeda Gold: Cooley LLP Silver: Blueprint Medicines, Sarepta Therapeutics, and Thermo Fisher Scientific Bronze: Agios Pharmaceuticals, Alnylam Pharmaceuticals, Beam Therapeutics, Collegium Pharmaceutical, Inc., J.P. Morgan, PwC, Sanofi, Scholar Rock, stet vision LLC, Trinity Life Sciences, and WilmerHale Friend: Aera Therapeutics, Alexion Pharmaceuticals, Arbor Biotech, Biogen, The Bowdoin Group, Camp4 Therapeutics, CFGI, City Therapeutics, Corsera Health, Corval, enGene, Gallagher, Hemab, JMM Innovations, Kymera Therapeutics, Leerink Partners, Marsh McLennan Agency, MassBio, McDermott Will & Emery, Morgan Stanley, The NemetzGroup, Newfront, Nimbus Therapeutics, Orbital Therapeutics, PathAI, Q32 Bio, Rapport Therapeutics, Schr?dinger, Synterex, Third Rock Ventures, Triumvirate Environmental, Vigil Neuro, and Xilio Therapeutics We are very close to selling out! If you'd like to be a sponsor, please reach out to?Emily Stanford: [email protected].

Welcome, Emma Mignacca, a political science major at College of the Holy Cross, who is our newest Project Onramp intern! She'll be a clinical operations and marketing intern at K36 Therapeutics, Inc. this summer. Thanks to Soo Bang and the team at K36 for providing valuable hands-on experience and an "onramp" for Emma and other promising young interns.

We are thrilled to announce that Rosie Cunningham will be joining Life Science Cares Boston as our new executive director, starting on March 26! Rosie brings wide-ranging experience in the nonprofit and private sectors, most recently as chief operating officer of the Family Reach Foundation, a national nonprofit focused solely on helping people with cancer access food, housing, utilities, and transportation. She’s held various leadership positions at Family Reach over the last ten years, serving as the key driver of both revenue and programmatic growth, as well as strategic alliances. She has also worked at the Livestrong Foundation and in sales and marketing roles in the educational publishing industry. Rosie’s expertise in nonprofit operations, fundraising, finance, and communications will position her well for LSC Boston’s next phase of growth and community impact, particularly with the organization’s 10th anniversary in 2026. Special thanks to Leane Marchese, CFRE for her help as interim executive director during the search and transition! Please join us in welcoming Rosie to the LSC family! We’re excited for what’s ahead under her leadership. Stay tuned for updates as she begins this new journey with us. #LifeScienceCares #Leadership #Boston

Kaitlyn Taliaferro is a biomedical engineering major at Tufts University and our newest Project Onramp intern! She'll be joining the Beam Therapeutics team this summer as a regulatory affairs intern. Thanks to Ashley Jefferson, Nicole Laroche, and everyone at Beam for partnering with Project Onramp on these transformational summer experiences!

We are thrilled to announce the launch of our Network of Good tool—or NOG, for short! NOG is a user-friendly digital tool that allows companies of any size to find, track, and report on volunteer opportunities—in an easy to use and centralized platform. This exciting addition—created by LSC to help streamline how our Corporate and Nonprofit Partners connect and collaborate with each other—is being rolled out today across all five of our locations: Boston, New York, Philadelphia, San Diego, and the San Francisco Bay Area. Reach out if you’d like to learn more about this innovative tool! ??If you are already a Corporate Partner, you’ll be hearing more about this in the coming days?? #NetworkOfGood #Volunteer #GivingBack